Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Cancer (r)evolution

Subjects

Cancer evolution is central to poor outcomes of cancer therapies, enabling tumour progression and the acquisition of drug resistance. Joint efforts of evolutionary biologists, oncologists and cancer researchers are necessary to understand the principles of cancer evolution and to derive therapeutic strategies that can control it.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Gerlinger, M. et al. Annu. Rev. Genet. 48, 215–236 (2014).

    Article  CAS  PubMed  Google Scholar 

  2. Gerlinger, M. et al. Nat. Genet. 46, 225–233 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra224 (2014).

    Article  Google Scholar 

  4. Gundem, G. et al. Nature 520, 353–357 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Prasad, V. Nature 537, S63 (2016).

    Article  CAS  PubMed  Google Scholar 

  6. Matsushita, H. et al. Nature 482, 400–404 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Siravegna, G. et al. Nat. Med. 21, 795–801 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gao, R. et al. Nat. Genet. 48, 1119–1130 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jamal-Hanjani, M. et al. PLoS Biol. 12, e1001906 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Barber, L. J., Davies, M. N. & Gerlinger, M. Curr. Opin. Genet. Dev. 30, 1–6 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lipinski, K. A. et al. Trends Cancer 2, 49–63 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Enriquez-Navas, P. M. et al. Sci. Transl. Med. 8, 327ra324 (2016).

    Article  Google Scholar 

  14. Harris, R. S. Breast Cancer Res. 17, 8 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Drake, C. G., Lipson, E. J. & Brahmer, J. R. Nat. Rev. Clin. Oncol. 11, 24–37 (2014).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Gerlinger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

von Loga, K., Gerlinger, M. Cancer (r)evolution. Nat Ecol Evol 1, 1051–1052 (2017). https://doi.org/10.1038/s41559-017-0252-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41559-017-0252-1

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer